Mindy Magee

788 citations

41 papers · 567 indexed · h-index 14

Impact in

Virology top 10%
- HIV Research and Treatment
Endocrinology, Diabetes and Metabolism top 10%
- Hormonal and reproductive studies

Papers in ⓘ

Virology 8
- HIV Research and Treatment 8
Hepatology 9
- Hepatitis C virus research 8

Co-authors: Christian D. Lates (3 shared papers)Robert A. Blum (3 shared papers)William J. Jusko (4 shared papers)Richard V. Clark (2 shared papers)Arun Mandagere (4 shared papers)Peter Ackerman (9 shared papers)Cyril Llamoso (8 shared papers)Duncan Richards (3 shared papers)
Journals: Clinical Pharmacology & Therapeutics (7 papers)The Journal of Clinical Pharmacology (5 papers)British Journal of Clinical Pharmacology (5 papers)Journal of Hepatology (2 papers)Open Forum Infectious Diseases (2 papers)
Partner nations: United States United Kingdom Germany

In The Last Decade

Mindy Magee

40 papers receiving 557 citations

Peers

Countries citing papers authored by Mindy Magee

Since Specialization

Citations

This map shows the geographic impact of Mindy Magee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mindy Magee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mindy Magee more than expected).

Fields of papers citing papers by Mindy Magee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mindy Magee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mindy Magee. The network helps show where Mindy Magee may publish in the future.

Co-authors

The 25 scholars most cited alongside Mindy Magee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mindy Magee Line = papers co-authored together Mindy Magee links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Prednisolone Pharmacokinetics and Pharmacodynamics in Relation to Sex and Race The Journal of Clinical Pharmacology ·Mindy Magee, Robert A. Blum, Christian D. Lates, William J. Jusko	2001	90
2	GSK2881078, a SARM, Produces Dose-Dependent Increases in Lean Mass in Healthy Older Men and Women The Journal of Clinical Endocrinology & Metabolism ·David Neil, Richard V. Clark, Mindy Magee, Julia Billiard, A K L Chan, Zhengyu Xue, Alan J. Russell	2018	48
3	A Randomized Phase 2 Study of an Anti–Amyloid β Monoclonal Antibody in Geographic Atrophy Secondary to Age-Related Macular Degeneration Ophthalmology Retina ·Philip J. Rosenfeld, Brian B. Berger, Elias Reichel, Ronald P. Danis, Angie Gress, Ye Li, Mindy Magee, Laura R. Parham, Megan McLaughlin	2018	46
4	Safety, pharmacokinetics and pharmacological effects of the selective androgen receptor modulator, GSK2881078, in healthy men and postmenopausal women British Journal of Clinical Pharmacology ·Richard V. Clark, Ann C. Walker, Susan Andrews, Philip Turnbull, Jeffrey A. Wald, Mindy Magee	2017	41
5	Pharmacokinetic/pharmacodynamic model for prednisolone inhibition of whole blood lymphocyte proliferation British Journal of Clinical Pharmacology ·Mindy Magee, Robert A. Blum, Christian D. Lates, William J. Jusko	2002	38
6	Darapladib, a Lipoprotein-Associated Phospholipase A2 Inhibitor, in Diabetic Macular Edema Ophthalmology ·Giovanni Staurenghi, Ye Li, Mindy Magee, Ronald P. Danis, John I. Wurzelmann, Peter Adamson, Megan McLaughlin	2015	37
7	Effect of Ketoconazole on the Pharmacokinetic Profile of Ambrisentan The Journal of Clinical Pharmacology ·Duncan Richards, Gennyne Walker, Arun Mandagere, Mindy Magee, Linda S. Henderson	2009	26
8	Potential for Pharmacokinetic Interactions Between Ambrisentan and Cyclosporine Clinical Pharmacology & Therapeutics ·Rebecca Spence, Arun Mandagere, Duncan Richards, Mindy Magee, Christopher Dufton, Ramesh Boinpally	2010	25
9	Pharmacokinetic and pharmacodynamic interactions between diltiazem and methylprednisolone in healthy volunteers Clinical Pharmacology & Therapeutics ·Brent M. Booker, Mindy Magee, Robert A. Blum, Christian D. Lates, William J. Jusko	2002	19
10	Platelet Aggregation Unchanged by Lipoprotein-Associated Phospholipase A2 Inhibition: Results from an In Vitro Study and Two Randomized Phase I Trials PLoS ONE ·Bonnie C. Shaddinger, Yanmei Xu, James Roger, Colin H. Macphee, M. Händel, Charlotte A. Baidoo, Mindy Magee, John J. Lepore, Dennis L. Sprecher	2014	17
11	Effects of Temsavir, Active Moiety of Antiretroviral Agent Fostemsavir, on QT Interval: Results From a Phase I Study and an Exposure–Response Analysis Clinical and Translational Science ·Chakradhar V. Lagishetty, Katy Moore, Peter Ackerman, Cyril Llamoso, Mindy Magee	2020	17
12	Effects of Rifampicin (Rifampin) on the Pharmacokinetics and Safety of Ambrisentan in Healthy Subjects Clinical Drug Investigation ·Brooke C. Harrison, Mindy Magee, Arun Mandagere, Gennyne Walker, Christopher Dufton, Linda S. Henderson, Ramesh Boinpally	2010	16
13	Industrial Perspective on the Benefits Realized From the FDA’s Model‐Informed Drug Development Paired Meeting Pilot Program Clinical Pharmacology & Therapeutics ·Gerald R. Galluppi, Satjit Brar, Luzelena Caro, Yuan Chen, Nicolas Frey, Hans Peter Grimm, Deanne Jackson Rudd, Chi‐Chung Li, Mindy Magee, Arnab Mukherjee, Lee M. Nagao, Vivek S. Purohit, Amit Roy, Ahmed Hamed Salem, Vikram Sinha, Ahmed A. Suleiman, Kunal S. Taskar, Vijay Upreti, Benjamin Weber, Jack Cook	2021	16
14	Disposition and Metabolism of Darapladib, a Lipoprotein-Associated Phospholipase A2 Inhibitor, in Humans Drug Metabolism and Disposition ·Mehul Dave, Mike Nash, Graeme Young, Harma Ellens, Mindy Magee, Andrew D. Roberts, Maxine Taylor, Robert W. Greenhill, Gary W. Boyle	2013	13
15	Methadone and buprenorphine pharmacokinetics and pharmacodynamics when coadministered with fostemsavir to opioid‐dependent, human immunodeficiency virus seronegative participants British Journal of Clinical Pharmacology ·Katy Moore, Mindy Magee, Heather Sevinsky, Ming Chang, Susan Lubin, Elsa Myers, Peter Ackerman, Cyril Llamoso	2019	11
16	2500. Fostemsavir Drug–Drug Interaction Profile, an Attachment Inhibitor and Oral Prodrug of Temsavir, for Heavily Treatment Experienced HIV-1-Infected Patients Open Forum Infectious Diseases ·Katy Moore, A Savannah Mageau, Mindy Magee, Peter D. Gorycki, Peter Ackerman, Cyril Llamoso	2019	11
17	Pharmacokinetics of Temsavir, the Active Moiety of the HIV-1 Attachment Inhibitor Prodrug, Fostemsavir, Coadministered with Cobicistat, Etravirine, Darunavir/Cobicistat, or Darunavir/Ritonavir with or without Etravirine in Healthy Participants Antimicrobial Agents and Chemotherapy ·Katy Moore, Nilay Thakkar, Mindy Magee, Heather Sevinsky, Blisse Vakkalagadda, Susan Lubin, Cyril Llamoso, Peter Ackerman	2022	8
18	Effects of Multiple Doses of Ambrisentan on the Pharmacokinetics of a Single Dose of Digoxin in Healthy Volunteers The Journal of Clinical Pharmacology ·Duncan Richards, Rebecca Spence, Arun Mandagere, Linda S. Henderson, Mindy Magee	2010	8
19	Pharmacokinetics of Temsavir, the Active Moiety of the Prodrug Fostemsavir, in Subjects with Hepatic Impairment Open Forum Infectious Diseases ·Heather Sevinsky, Mindy Magee, Peter Ackerman, Robert Adamczyk, Jennifer Karkas, Susan Lubin, Palanikumar Ravindran, Cyril Llamoso, Timothy Eley, Katy Moore	2017	8
20	Effect of Renal and Hepatic Impairment on the Pharmacokinetics of Temsavir, the Active Moiety of Fostemsavir The Journal of Clinical Pharmacology ·Mindy Magee, Jill Slater, Frank Mannino, Peter Ackerman, Cyril Llamoso, Katy Moore	2020	7

About Mindy Magee

Mindy Magee is a scholar working on Virology, Hepatology, Infectious Diseases, Genetics and Pharmacology, having authored 41 papers that have together received 567 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (12 papers), HIV Research and Treatment (8 papers), Hepatitis C virus research (8 papers), HIV/AIDS Research and Interventions (6 papers), Hepatitis B Virus Studies (6 papers), Pulmonary Hypertension Research and Treatments (4 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Pharmacological Effects and Toxicity Studies (3 papers). The work is most often cited by research in Virology (55 citations), Endocrinology, Diabetes and Metabolism (119 citations), Pharmacology (56 citations), Ophthalmology (54 citations) and Transplantation (15 citations). Mindy Magee has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Christian D. Lates, Robert A. Blum, William J. Jusko, Richard V. Clark, Arun Mandagere, Peter Ackerman, Cyril Llamoso, Duncan Richards, Ronald P. Danis and Ye Li. Their work appears in journals such as Clinical Pharmacology & Therapeutics, The Journal of Clinical Pharmacology, British Journal of Clinical Pharmacology, Journal of Hepatology and Open Forum Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact